BioNTech co-founder Ugur Sahin among world 500 richest people: Bloomberg

Published On 2020-12-06 05:00 GMT   |   Update On 2020-12-06 05:00 GMT
Advertisement

New Delhi: Ugur Sahin just reached another milestone. The co-founder of BioNTech SE on Thursday joined the world's 500 richest people after the UK this week approved use of a vaccine that the German firm created with Pfizer Inc.

BioNTech's shares have jumped almost 8% this week and are up over 250% for the year. Sahin is now the 493rd-richest person on the planet with a net worth of $5.1 billion, according to Bloomberg Billionaires Index. Sahin didn't reply to a request for comment.
Advertisement
Turkish-born scientist Sahin is the sole shareholder of a German firm that controls an 18% stake in BioNTech, which raised $150 million from its US initial public offering last year, filings show. Sahin joins Germany's Struengmann brothers among the world's 500 richest. They own about half of BioNTech and their fortune is estimated at more than $24 billion combined.
The race to produce a Covid-19 vaccine has also lifted a group of investors at Moderna. Shares of the Massachusetts based firm have surged over 700% this year, making billionaires of some early investors, including MIT professor Bob Langer and Harvard professor Tim Springer, as well as CEO Stephane Bancel, who is now worth $4.9 billion.

Read also: UK poised to become first country to approve Pfizer vaccine: Bloomberg



Tags:    
Article Source : Bloomberg

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News